Skip to main content

12 publications

Name Date Type Actions

Mis en oeuvre des recommandations AFEP/MEDEF du 6 octobre 2008 sur les rémunérations des dirigeants mandataires sociaux des sociétés cotées

Lors de sa réunion du 5 décembre 2008, le Conseil d’administration a pris connaissance des recommandations AFEP-MEDEF du 8 octobre 2008 sur la rémunération des dirigeants sociaux des sociétés cotées.

22/12/2008 Public releases

Vétoquinol strengthens its position in Europe with the acquisition of Ascor Chimici in Italy

Vétoquinol announces the signing of a contract to acquire 100 percent of the shares of Ascor Chimici S.r.l, which will take effect on 1 December 2008.

25/11/2008 Public releases

Revenues for the first nine months of 2008

Revenues increased by 3.1% during the first 9 months of 2008 to 171.2 million euros (4.8% on a like-for-like basis).

22/10/2008 Public releases

Vétoquinol: 2008 results expected to be in line with objectives

At its meeting of 25 August 2008, the Board of Directors of Vétoquinol S.A. reviewed the Group’s operations and approved the financial statements for
the first half of 2008.

27/08/2008 Public releases

2008 Interim Revenues increase by 5%

Vétoquinol generated revenues of 116.7 million euros in the first half of 2008, a 5% increase over the 111.1 million euros
reported the previous year.

22/07/2008 Public releases

Pierre Konareff est nommé Directeur Financier et Juridique du Groupe Vétoquinol (french)

Vétoquinol annonce la nomination de Pierre Konareff au poste de Directeur Financier et Juridique du groupe.

08/07/2008 Public releases

Vétoquinol strengthens its presence in Canada in the compagnion animal market

Vétoquinol announces the acquisition of the animal health business assets of VETCOM 1979 INC. The animal health business of VETCOM 1979 INC. includes annual revenue of around CAD1.5 million. The company covers nearly 65% of the market for ophthalmological unguents in Canada.

01/07/2008 Public releases

Satisfactory revenue growth for 1st quarter 2008: +4.6% on a constant basis

Revenue for the first quarter of 2008 reached €54.7 M, an increase of 3.0% over the first quarter of 2007, a high revenue growth period. First quarter 2008 growth was particularly significant for the livestock segment.

06/05/2008 Public releases

Earnings for 2007 attest to strength of business growth model

The Vétoquinol board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements. In 2007, Vétoquinol once again achieved significant improvement in its key performance
indicators, ahead of its medium-term targets. According to the most recent statistics published by Vetnosis, this substantial rise in revenue has lifted Vétoquinol to third place
worldwide.

18/03/2008 Public releases

VÉTOQUINOL S.A. and JUROX PTY LTD extend their collaboration on ALFAXAN® in Europe

17/03/2008 Public releases